bioRxivGenomicsPreprint
Predicted Effector Gene Aggregation, Standards and Unified Schema (PEGASUS): A Community Framework for Effector Gene Reporting
Aoife McMahoniD, Yue JiiD, Maria C. CostanzoiD, Adam S. ButterworthiD, Matthew C. PahliD, Szymon SzyszkowskiiD, Karl HeilbroniD, Abdurrahman Shiyanbola, Yakov A. TsepiloviD, Cassandra Nichole SprackleniD, Jeremy A. ArbesfeldiD, Drew Hite, PEG Working GroupiD, Elizabeth LewisiD, Helen ParkinsoniD, Noël P. BurttiD, Laura Wiseman HarrisiD
Abstract
Genome-wide association studies (GWAS) increasingly report predicted effector genes (PEGs) - genes hypothesised to mediate the biological effects of associated variants. These function as key outputs for advancing variant-to-function research, mechanistic understanding, and therapeutic discovery. However, the rapid growth of PEG lists has not been matched by standards for organising, annotating, and reporting these predictions. As shown by recent landscape analyses, PEG lists vary widely in methodology, evidence definition, nomenclature, provenance tracking, and data structure, limiting interoperability, benchmarking, reuse, and adherence to FAIR principles. To address this gap, we convened an international multi-stakeholder community comprising method developers, data generators, resource maintainers, curators, funders, journal editors, and downstream users. Through a 2024 workshop and a 2025 working group series, we developed the Predicted Effector Gene Aggregation, Standards and Unified Schema (PEGASUS) framework. PEGASUS specifies (i) a metadata standard to capture provenance, trait and GWAS descriptors, evidence sources, and integration methods; (ii) a structured evidence matrix reporting all genes and all evidence underpinning prioritisation at each locus; and (iii) a concise PEG list that summarises author-prioritised genes linked transparently to underlying evidence. The framework balances transparency, machine readability, burden on submitters, and alignment with existing community standards. PEGASUS provides the first community-developed schema for reporting predicted effector genes and their supporting evidence. Adoption of this framework by authors will improve the comparability, reproducibility, and reusability of PEG outputs across studies, facilitating more robust biological inference, enabling cross-resource comparison of gene-prioritisation methods to support community benchmarking, and integration into downstream resources and analytical pipelines. PEGASUS-compliant data can be shared via the PEG Data Registry platform (https://kpndataregistry.org/peg), promoting re-use and establishing the basis for future integration with publicly shared GWAS data.
- organism: human
- assay: GWAS summary statistics
- research focus: database / resource
- research focus: GWAS / association mapping
- research focus: benchmarking
- research focus: software / tool
- approach: statistical model
- approach: benchmark study
In-depth summary
Claude Opus 5.5 · xhigh effort · 8 Nov 2026 · from the full text of version 3 (30 Sept 2026) · CC BY 4.0
PEGASUS defines a community reporting standard for GWAS predicted effector genes: a metadata record, a full locus-by-gene evidence matrix, and a derived author-prioritised gene list.
Predicted effector gene (PEG) lists from GWAS feed functional follow-up, drug target discovery and training of gene-prioritisation models, yet a landscape review found they vary widely in evidence definitions, metadata, provenance and format. PEGASUS is described as the first community-developed reporting schema for PEGs; it separates an exhaustive evidence matrix from a summary gene list, mirroring GWAS summary statistics versus lead hits, and deliberately prescribes no scoring method.
Key results
ShownPEGASUS splits PEG reporting into three linked products per GWAS trait: a metadata record, an evidence matrix covering every gene and evidence item considered at each locus, and a PEG list of author-prioritised genes linked back to that evidence.
Each analysed GWAS dataset yields one metadata record, one evidence matrix and a PEG list. Matrix rows are variant-gene pairs at a locus; columns hold evidence types, provenance fields or optional integration scores. The list is pulled from the matrix via an author_conclusion column. The split mirrors full GWAS summary statistics versus lead associations. · Introduction; Overview of the PEGASUS framework; Evidence matrix; PEG list
ShownA controlled vocabulary sorts evidence into variant-centric and gene-centric categories. Finer-grained streams sit under each category, so new evidence types can be added without redesigning the schema.
Variant-centric examples: statistical fine-mapping, credible set membership, chromatin interactions, QTLs, clinically relevant variants. Gene-centric examples: expression, perturbation experiments, gene set associations, gene burden analyses, literature. Category vs stream example: QTL analysis containing eQTL and sQTL streams (Figure 4, Table S1). · Evidence matrix; Organisation of evidence categories
ShownA machine-readable metadata standard records the context needed to interpret a PEG output. It has a small mandatory core plus recommended fields that link to external ontologies and resources.
Fields cover trait ontology IDs plus a readable description; GWAS accession, sample characteristics, genome build and publications; locus definition (method, window size or fine-mapping) and gene-to-locus rules; evidence sources, categories and biosamples; any integration method; column definitions. genome_build is mandatory, variant_type recommended; files in YAML or JSON. · Metadata standard
SuggestedIn working-group implementation tests, PEGASUS reportedly fit every tested PEG dataset without changes to the original analyses. Testers judged the conversion effort similar to submitting to established genomic repositories.
Members reformatted previously published PEG outputs and their own analyses, spanning different evidence types, traits and integration strategies. Their own outputs converted easily; legacy outputs needed extra curation where provenance or context was missing. No dataset counts or timings are reported. · Design principles, usability and implementation…; Implementation outcomes and experience
ShownTwo worked examples show the format end to end: a synthetic dataset converted into metadata, matrix and list, and one published locus from Aragam et al. (2022) re-expressed in PEGASUS without re-running its analysis.
Synthetic data (Supplemental File 2 and online documentation) is traced from raw input to a metadata entity-relationship model for QTL evidence (method e.g. FastQTL, source e.g. GTEx) to the evidence matrix (Figure 3) and PEG list (Figure 2B). The Aragam et al. (2022) locus is in Supplemental File 3; a metadata template is Supplemental File 4. · Worked example with synthetic and real data; Data sharing; Description of Supplemental files; Figure legends
Methods, data and reproducibility
A multi-stakeholder working group designed the schema through a systematic review of published PEG lists, a September 2024 workshop (presentations, surveys, breakout sessions) and a 2025 working group series. Volunteers then tested the drafts by reformatting published PEG outputs and their own, and synthetic and real worked examples were built.
- Published PEG lists from complex trait and disease GWAS (systematic landscape review)
- Workshop presentations, surveys and breakout feedback from PEG contributors and users, September 2024 (Supplemental File 1)
- Previously published and working-group members' own PEG outputs reformatted during implementation testing
- Synthetic PEG dataset in PEGASUS format: metadata, evidence matrix, PEG list (Supplemental File 2)
- PEG output from Aragam et al. (2022), reformatted into PEGASUS (Supplemental File 3) · n = a single locus
- Methods & tools
- GWAS Catalog, PEG Data Registry, Predicted Effector Gene Knowledge Portal (PEGKP), Knowledge Portal Network, Evidence and Conclusion Ontology (ECO), EDAM, Ontology for Biomedical Investigations (OBI), YAML / JSON
- Data & accessions
- https://kpndataregistry.org/peghttps://www.pegkp.org/https://kp4cd.org/2024_PEG_workshop
- Reproducibility gaps
- Dedicated validation and submission tools are listed as future work (a metadata template, Supplemental File 4, and the PEG Data Registry submission platform exist). Implementation-testing outcomes are qualitative, with no count of converted datasets or conversion times.
Limitations (6)
- Mapping of PEGASUS evidence categories onto the Evidence and Conclusion Ontology (ECO) is incomplete. Several PEGASUS evidence types have no direct ECO term, and the authors flag closing these gaps as high-priority future work. · stated by the authors
- The authors acknowledge that the list of evidence sub-categories (streams) is not exhaustive and may change as methods evolve. · stated by the authors
- The PEG list marks only which evidence categories were considered, not their direction, strength or consistency. It does not yet capture negative or conflicting evidence. · stated by the authors
- Testers reported some uncertainty when mapping authors' evidence descriptions into structured fields, and said lightweight tooling, templates and validation tools would help metadata entry. A metadata template is provided (Supplemental File 4); validation and submission tools are listed as future work. · stated by the authors
- The evidence for feasibility comes from working-group members testing their own standard. It is reported qualitatively, without counts of datasets, conversion times or agreement between independent curators. · noted in this summary
- The claimed gains for benchmarking, interoperability and reuse are argued rather than measured. The paper runs no cross-study comparison or benchmark on PEGASUS-formatted data. · noted in this summary
Read this if you publish or reuse GWAS gene-prioritisation results, train or benchmark locus-to-gene models, or curate effector-gene data for a database.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The NHGRI-EBI GWAS Catalog: standards for reusability, sustainability and diversity
María Cerezo, Elliot Sollis, … Laura Wiseman Harris·Nucleic Acids ResearchPeer-reviewed·Oct 22, 2024
- Scaling genetic discovery through automated post-GWAS interpretation
- PolyGenie: a reproducible Nextflow pipeline for phenome-wide association studies using polygenic risk scores
Xavier Farré, Mireia Gasco, … Rafael de Cid·NAR Genomics and BioinformaticsPeer-reviewed·Mar 27, 2026
- PGSFusion streamlines polygenic score construction and epidemiological applications in biobank-scale cohorts
Sheng Yang, Xiangyu Ye, … Cao Chen·bioRxiv·Aug 5, 2024
- Kernelized approach enables explainable gene prioritizations for complex traits
Taotao Tan, Md. Abul Hassan Samee·bioRxiv·Jul 10, 2026
- An Effector Index to Predict Causal Genes at GWAS Loci
Vincenzo Forgetta, Lai Jiang, … John Brent Richards·Human GeneticsPeer-reviewed·Feb 11, 2022